April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
April 21, 2026
According to market projections, the glutamine sector is expected to grow from USD 135.13 million in 2024 to USD 185.16 million by 2034, reflecting a CAGR of 3.2%.The glutamine market was dominated by L-glutamine, the biologically active form used for protein synthesis in 2023. The powder segment led due to its convenience and stability. Offline re...
April 21, 2026
Based on market forecasts, the atrial fibrillation treatment sector will expand from USD 24.26 billion in 2024 to USD 40.27 billion by 2034, experiencing a CAGR of 5.2%. Atrial fibrillation is a heart rhythm problem where the upper chambers quiver, raising the risk of blood clots. Causes include high blood pressure, heart disease, and sleep apnea. ...
April 21, 2026
Forecasts suggest that the synovial sarcoma treatment market will expand from USD 852.36 million in 2024 to USD 1214 million by 2034, with a CAGR of 3.6% during this period. In 2023, surgery remained the leading treatment, holding a dominant 56% market share. North America led the market, accounting for 41% of the total share....
April 21, 2026
According to market projections, the autoimmune hepatitis diagnosis and treatment sector is expected to grow from USD 14.49 billion in 2024 to USD 20.05 billion by 2034, reflecting a CAGR of 3.3%. The autoimmune hepatitis diagnosis and treatment market focuses on tests and therapies for managing autoimmune hepatitis, a condition where the immune sy...
April 21, 2026
According to market projections, the vein finder sector is expected to grow from USD 53.43 million in 2024 to USD 123.04 million by 2034, reflecting a CAGR of 8.7%. In 2023, near-infrared technology led the vein finder market with a 57% share, while tabletop models dominated at 55%. Hospitals and clinics were the top users, holding 62% of the marke...
April 21, 2026
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
April 21, 2026
According to market projections, the newborn screening sector is expected to grow from USD 3.44 billion in 2024 to USD 6.46 billion by 2034, reflecting a CAGR of 6.5%. The market is growing due to rising demand for preventive care, advanced diagnostic technologies, and increased awareness of testing. Recent highlights include the GUARDIAN study usi...
April 21, 2026
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest growth ahead. Cholinesterase inhibitors dominated by product, but pipeline drugs are expected to gro...
April 21, 2026
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
